Regulation of GDF-8 signaling by the p38 MAPK
- PMID: 15567067
- DOI: 10.1016/j.cellsig.2004.08.003
Regulation of GDF-8 signaling by the p38 MAPK
Abstract
Growth differentiation factor-8 (GDF-8), a member of the TGF-beta superfamily, is a negative regulator of skeletal muscle growth, which functions through activation of the Smad proteins. We found that GDF-8 can activate the p38 mitogen-activated protein kinase (MAPK) through the TGF-beta-activated kinase 1 (TAK1), and this appeared to be independent of Smad signaling. GDF-8-induced transcriptional activation was inhibited by expression of dominant negative MKK6 or treatment with the p38 inhibitor SB203580, while overexpression of wild-type forms of either MKK6 or p38 augmented GDF-8-induced transcriptional activity. In addition, ATF-2, a known transcription factor target of p38, was found to be phosphorylated on GDF-8 stimulation and was detected in a complex with Smad3/Smad4 upon GDF-8 treatment. Furthermore, we found that the p38 MAPK played an important role in GDF-8-induced inhibition of proliferation and upregulation of the cyclin kinase inhibitor p21. Together, these results highlight a functional link between the p38 MAPK and GDF-8-activated Smad pathways, and identify a critical role for the p38 MAPK in GDF-8's function as a negative regulator of muscle growth.
Similar articles
-
Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-beta-induced gene expression.J Biol Chem. 1999 Sep 17;274(38):27161-7. doi: 10.1074/jbc.274.38.27161. J Biol Chem. 1999. PMID: 10480932
-
Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chondrogenic ATDC5 cells.J Biol Chem. 2001 Apr 27;276(17):14466-73. doi: 10.1074/jbc.M005724200. Epub 2001 Jan 29. J Biol Chem. 2001. PMID: 11278290
-
Regulation of biglycan gene expression by transforming growth factor-beta requires MKK6-p38 mitogen-activated protein Kinase signaling downstream of Smad signaling.J Biol Chem. 2003 Mar 28;278(13):11041-9. doi: 10.1074/jbc.M300035200. Epub 2003 Jan 20. J Biol Chem. 2003. PMID: 12538652
-
Molecular basis and therapeutic potential of myostatin on bone formation and metabolism in orthopedic disease.Biofactors. 2023 Jan;49(1):21-31. doi: 10.1002/biof.1675. Epub 2020 Sep 30. Biofactors. 2023. PMID: 32997846 Review.
-
Role and Mechanism of Growth Differentiation Factor 15 in Chronic Kidney Disease.J Inflamm Res. 2024 May 9;17:2861-2871. doi: 10.2147/JIR.S451398. eCollection 2024. J Inflamm Res. 2024. PMID: 38741613 Free PMC article. Review.
Cited by
-
Aberrant repair and fibrosis development in skeletal muscle.Skelet Muscle. 2011 May 4;1(1):21. doi: 10.1186/2044-5040-1-21. Skelet Muscle. 2011. PMID: 21798099 Free PMC article.
-
Understanding of sarcopenia: from definition to therapeutic strategies.Arch Pharm Res. 2021 Oct;44(9-10):876-889. doi: 10.1007/s12272-021-01349-z. Epub 2021 Sep 18. Arch Pharm Res. 2021. PMID: 34537916 Review.
-
Growth/differentiation factor 15 causes TGFβ-activated kinase 1-dependent muscle atrophy in pulmonary arterial hypertension.Thorax. 2019 Feb;74(2):164-176. doi: 10.1136/thoraxjnl-2017-211440. Epub 2018 Dec 15. Thorax. 2019. PMID: 30554141 Free PMC article.
-
Hyperhomocysteinemia inhibits satellite cell regenerative capacity through p38 alpha/beta MAPK signaling.Am J Physiol Heart Circ Physiol. 2015 Jul 15;309(2):H325-34. doi: 10.1152/ajpheart.00099.2015. Epub 2015 May 15. Am J Physiol Heart Circ Physiol. 2015. PMID: 25980021 Free PMC article.
-
Inflammation: Roles in Skeletal Muscle Atrophy.Antioxidants (Basel). 2022 Aug 29;11(9):1686. doi: 10.3390/antiox11091686. Antioxidants (Basel). 2022. PMID: 36139760 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous